Abstract 2755: Characterizing breast cancer cells following immune pruning in mice
Sarina McElduff,Daniel Bronder,Mercedes Duran,Samuel Bakhoum
DOI: https://doi.org/10.1158/1538-7445.am2024-2755
IF: 11.2
2024-03-28
Cancer Research
Abstract:In cancer patients, metastasis is the leading cause of death. Indeed, primary tumors which are diagnosed early and treated in a timely manner have the highest rate of success. In contrast, metastatic disease and late diagnosis of tumors portend poor outcomes. Thus, understanding the underlying biology and developing novel therapeutic approaches for metastatic cancers is pivotal. Most cancer-based mutational characteristics are tissue-dependent, and cancers with higher mutational load are generally more susceptible to immunotherapy. We observed that poorly metastatic, murine breast cancer cells established a clear phenotypic difference in lung metastasis formation assays. Upon injection of these cells into immune-proficient mice, few, large metastases developed, whereas in immuno-deficient mice, many small metastases grew instead. To determine the molecular features which enable escape under immune editing, we designed the following workflow. We intravenously injected immune-proficient and immune-deficient mice with our poorly metastatic, murine breast cancer cells. As expected, cells readily engrafted in the lungs, causing a significant reduction in survival of immune-deficient mice. Furthermore, liver metastases were observed only in immune-deficient mice. Upon euthanasia, we resected and dissociated both organs. To isolate the tumor cells from these samples, we flow-sorted and subjected them to next-generation sequencing. To elucidate the epigenomic, genomic, and transcriptomic differences between metastases of each background, we performed ATAC, WGS, and RNAseq, respectively. By dissecting the evolutionary mechanisms which allow cancer cells to evade immune detection in metastasis, we can develop targeted immunotherapy strategies to diminish the spread (and lethality) of metastatic cancers. In the future, we plan to examine the descriptive discrepancies between the tissues reared with and without immune pruning in order to put forward innovative therapeutic strategies. Citation Format: Sarina McElduff, Daniel Bronder, Mercedes Duran, Samuel Bakhoum. Characterizing breast cancer cells following immune pruning in mice [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 2755.
oncology